Advanced Neuroendocrine Neoplasm
2 clinical trials · Condition
◉ Watch Advanced Neuroendocrine Neoplasm
| Record | Firm | Date |
|---|---|---|
| A Clinical Study of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine Neoplasms (NCT06398444) | Sinotau Pharmaceutical Group | 2024-06-11 |
| Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome (NCT04776876) | M.D. Anderson Cancer Center | 2021-03-01 |
Track Advanced Neuroendocrine Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.